{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T12:35:00Z","timestamp":1775910900443,"version":"3.50.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.beem.2010.10.001","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T06:01:49Z","timestamp":1291096909000},"page":"923-932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Treatment of primary aldosteronism"],"prefix":"10.1016","volume":"24","author":[{"given":"Marcus","family":"Quinkler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2010.10.001_bib1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"Journal of American College of Cardiology"},{"key":"10.1016\/j.beem.2010.10.001_bib2","first-page":"394","article-title":"The aldosterone\/renin ratio as a screening test for primary aldosteronism","volume":"90","author":"Rayner","year":"2000","journal-title":"South African Medical Journal"},{"key":"10.1016\/j.beem.2010.10.001_bib3","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib4","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.beem.2010.10.001_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"Journal of Human Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.beem.2010.10.001_bib8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","article-title":"Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity","volume":"51","author":"Schwartz","year":"2005","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.beem.2010.10.001_bib10","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2010.10.001_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/HYPERTENSIONAHA.106.086124","article-title":"Is there an unrecognized epidemic of primary aldosteronism?","volume":"50","author":"Kaplan","year":"2007","journal-title":"Controversies in Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib13","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib14","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"Journal of Human Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib16","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/dc07-0031","article-title":"Primary aldosteronism in diabetic subjects with resistant hypertension","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2010.10.001_bib17","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.beem.2010.10.001_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.beem.2010.10.001_bib19","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2008-2116","article-title":"Cardio- and cerebrovascular comorbidites of hypo- and normokalemic primary aldosteronism: results of the German conn\u2019s registry","author":"Born-Frontsberg","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","article-title":"Cardiovascular complications in patients with primary aldosteronism","volume":"33","author":"Nishimura","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.beem.2010.10.001_bib21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.amjhyper.2006.02.002","article-title":"Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension","volume":"19","author":"Strauch","year":"2006","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib23","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1210\/jc.2006-0101","article-title":"Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism","volume":"91","author":"Rizzoni","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0735-1097(98)00322-2","article-title":"Relations between cardiac and vascular structure in patients with primary and secondary hypertension","volume":"32","author":"Rizzoni","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.beem.2010.10.001_bib25","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/HJH.0b013e32831286fd","article-title":"Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism","volume":"26","author":"Bernini","year":"2008","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib26","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/HJH.0b013e3281268532","article-title":"Increased intima-media thickness of the common carotid artery in primary aldosteronism in comparison with essential hypertension","volume":"25","author":"Holaj","year":"2007","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.02898.x","article-title":"Diagnosis and treatment of low-renin hypertension","volume":"67","author":"Mulatero","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/j.beem.2010.10.001_bib28","author":"Quinkler","year":"2006","journal-title":"Der Internist"},{"key":"10.1016\/j.beem.2010.10.001_bib29","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","author":"Funder","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","article-title":"Primary aldosteronism: factors associated with normalization of blood pressure after surgery","volume":"135","author":"Sawka","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2010.10.001_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00268-004-7496-z","article-title":"Long-term follow-up after adrenalectomy for primary aldosteronism","volume":"29","author":"Meyer","year":"2005","journal-title":"World Journal of Surgery"},{"key":"10.1016\/j.beem.2010.10.001_bib32","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","article-title":"Factors influencing outcome of surgery for primary aldosteronism","volume":"131","author":"Celen","year":"1996","journal-title":"Archives of Surgery"},{"key":"10.1016\/j.beem.2010.10.001_bib33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.7326\/0003-4819-121-11-199412010-00010","article-title":"Diagnosis and treatment of primary hyperaldosteronism","volume":"121","author":"Blumenfeld","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2010.10.001_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0748-7983(03)00051-9","article-title":"Review of surgical management of aldosterone secreting tumours of the adrenal cortex","volume":"29","author":"Harris","year":"2003","journal-title":"European Journal of Surgical Oncology"},{"key":"10.1016\/j.beem.2010.10.001_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1994.tb02520.x","article-title":"Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness","volume":"21","author":"Stowasser","year":"1994","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.beem.2010.10.001_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000658-199608000-00003","article-title":"Primary aldosteronism. Results of surgical treatment","volume":"224","author":"Lo","year":"1996","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.beem.2010.10.001_bib37","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1445-2197.2007.04225.x","article-title":"Outcomes of laparoscopic adrenalectomy for hyperaldosteronism","volume":"77","author":"Pang","year":"2007","journal-title":"ANZ Journal of Surgery"},{"key":"10.1016\/j.beem.2010.10.001_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","article-title":"Medical management of aldosterone-producing adenomas","volume":"131","author":"Ghose","year":"1999","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2010.10.001_bib39","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0022-5347(01)67303-8","article-title":"Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma","volume":"153","author":"Nakada","year":"1995","journal-title":"Journal of Urology"},{"key":"10.1016\/j.beem.2010.10.001_bib40","first-page":"40","article-title":"Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma","volume":"174","author":"Ishidoya","year":"2005","journal-title":"Journal d\u2018Urologie"},{"key":"10.1016\/j.beem.2010.10.001_bib41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/meta.2002.30498","article-title":"Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling","volume":"51","author":"Omura","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/pmj.76.893.160","article-title":"Recurrence of adrenal aldosterone-producing adenoma","volume":"76","author":"Calvo-Romero","year":"2000","journal-title":"Postgraduate Medical Journal"},{"key":"10.1016\/j.beem.2010.10.001_bib43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/HJH.0b013e3282f4b3e6","article-title":"Primary aldosteronism: an update on screening, diagnosis and treatment","volume":"26","author":"Rossi","year":"2008","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib44","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: primary aldosteronism-changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2010.10.001_bib45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0889-8529(18)30425-0","article-title":"Primary aldosteronism. Diagnostic evaluation","volume":"17","author":"Young","year":"1988","journal-title":"Endocrinology Metabolism Clinics of North America"},{"key":"10.1016\/j.beem.2010.10.001_bib46","first-page":"203","article-title":"Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism","volume":"27","author":"Baer","year":"1970","journal-title":"Circulation Research"},{"key":"10.1016\/j.beem.2010.10.001_bib47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archinte.1967.00300040052009","article-title":"Primary aldosteronism","volume":"120","author":"Gunnells","year":"1967","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.beem.2010.10.001_bib48","first-page":"761","article-title":"Primary aldosteronism: surgical management and pathologic findings","volume":"43","author":"Priestley","year":"1968","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.beem.2010.10.001_bib49","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-90-3-386","article-title":"Primary aldosteronism: diagnosis, localization, and treatment","volume":"90","author":"Weinberger","year":"1979","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2010.10.001_bib50","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience","volume":"94","author":"Sukor","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib51","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","article-title":"Update in primary aldosteronism","volume":"94","author":"Stowasser","year":"2009","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bmj.2.5816.729","article-title":"Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin","volume":"2","author":"Brown","year":"1972","journal-title":"British Medical Journal"},{"key":"10.1016\/j.beem.2010.10.001_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00000441-197012000-00001","article-title":"Effect of spironolactone in hypertensive patients","volume":"260","author":"Crane","year":"1970","journal-title":"American Journal of the Medical Sciences"},{"key":"10.1016\/j.beem.2010.10.001_bib54","doi-asserted-by":"crossref","first-page":"V115","DOI":"10.1161\/01.HYP.5.6_Pt_3.V115","article-title":"Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism","volume":"5","author":"Kater","year":"1983","journal-title":"Hypertension"},{"issue":"Suppl. 45","key":"10.1016\/j.beem.2010.10.001_bib55","first-page":"213s","article-title":"Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes","volume":"1","author":"Kremer","year":"1973","journal-title":"Clinical Science and Molecular Medicine Supplement"},{"key":"10.1016\/j.beem.2010.10.001_bib56","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","article-title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study","volume":"48","author":"Lim","year":"1999","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.beem.2010.10.001_bib57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF01476798","article-title":"Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading","volume":"58","author":"Helber","year":"1980","journal-title":"Klinische Wochenschrift"},{"key":"10.1016\/j.beem.2010.10.001_bib58","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1055\/s-2008-1070723","volume":"105","author":"Wambach","year":"1980","journal-title":"Deutsche Medizinische Wochenschrift"},{"key":"10.1016\/j.beem.2010.10.001_bib59","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"American Journal of Cardiology"},{"key":"10.1016\/j.beem.2010.10.001_bib60","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib61","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/S0149-2918(03)80282-5","article-title":"Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension","volume":"25","author":"Burgess","year":"2003","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.beem.2010.10.001_bib62","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2010.10.001_bib63","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","article-title":"Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism","volume":"9","author":"Karagiannis","year":"2008","journal-title":"Expert Opinion on Pharmacotherapy."},{"key":"10.1016\/j.beem.2010.10.001_bib64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","article-title":"A review of the medical treatment of primary aldosteronism","volume":"19","author":"Lim","year":"2001","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib65","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/heart.88.5.475","article-title":"Increasing plasma potassium with amiloride shortens the QT interval and reduces ventricular extra systoles but does not change endothelial function or heart rate variability in chronic heart failure","volume":"88","author":"Farquharson","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.beem.2010.10.001_bib66","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2010.10.001_bib67","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/HJH.0b013e32831b7687","article-title":"Diagnosis of primary aldosteronism: for medical management, not just surgery","volume":"27","author":"Spence","year":"2009","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib68","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1210\/jcem-47-5-938","article-title":"Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism","volume":"47","author":"Wisgerhof","year":"1978","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib69","first-page":"779","article-title":"The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism","volume":"5","author":"Griffing","year":"1983","journal-title":"Clinical and Experimental Hypertension"},{"issue":"Suppl. 61","key":"10.1016\/j.beem.2010.10.001_bib70","doi-asserted-by":"crossref","first-page":"289s","DOI":"10.1042\/cs061289s","article-title":"Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism","volume":"7","author":"Mantero","year":"1981","journal-title":"Clinical Science (London)"},{"key":"10.1016\/j.beem.2010.10.001_bib71","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/jcem-60-5-896","article-title":"Therapeutic effect of calcium channel blockade in primary aldosteronism","volume":"60","author":"Nadler","year":"1985","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"Suppl. 12","key":"10.1016\/j.beem.2010.10.001_bib72","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/00005344-198812006-00033","article-title":"Are calcium antagonists helpful in the management of primary aldosteronism?","volume":"6","author":"Stimpel","year":"1988","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.beem.2010.10.001_bib73","first-page":"1263","article-title":"Acute and chronic effect of nifedipine in primary aldosteronism","volume":"11","author":"Carpene","year":"1989","journal-title":"Clinical and Experimental Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib74","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF03348177","article-title":"Effect of verapamil on aldosterone secretion in primary aldosteronism","volume":"10","author":"Opocher","year":"1987","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.beem.2010.10.001_bib75","doi-asserted-by":"crossref","first-page":"88S","DOI":"10.1093\/ajh\/1.3.88S","article-title":"The absence of long-term therapeutic effect of calcium channel blockade in the primary aldosteronism of adrenal adenomas","volume":"1","author":"Bursztyn","year":"1988","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib76","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF01717327","article-title":"Therapeutic value of calcium antagonists in autonomous hyperaldosteronism","volume":"67","author":"Stimpel","year":"1989","journal-title":"Klinische Wochenschrift"},{"key":"10.1016\/j.beem.2010.10.001_bib77","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.107.103580","article-title":"A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity","volume":"51","author":"Dietz","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1677\/erc.1.00867","article-title":"Aldosterone-producing adrenocortical carcinoma: an unusual cause of conn\u2019s syndrome with an ominous clinical course","volume":"12","author":"Seccia","year":"2005","journal-title":"Endocrine Related Cancer"},{"key":"10.1016\/j.beem.2010.10.001_bib79","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-130-9-199905040-00017","article-title":"Adrenocortical tumors: recent advances in basic concepts and clinical management","volume":"130","author":"Bornstein","year":"1999","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.beem.2010.10.001_bib80","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib81","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1001\/jama.1977.03280240073028","article-title":"Mitotane. Spironolactone antagonism in cushing\u2019s syndrome","volume":"238","author":"Wortsman","year":"1977","journal-title":"Journal of American Medical Association"},{"key":"10.1016\/j.beem.2010.10.001_bib82","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.beem.2010.10.001_bib83","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.89.17.8327","article-title":"Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2","volume":"89","author":"Pascoe","year":"1992","journal-title":"Proceedings of National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.beem.2010.10.001_bib84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0960-0760(01)00097-8","article-title":"Familial hyperaldosteronism","volume":"78","author":"Stowasser","year":"2001","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.beem.2010.10.001_bib85","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1067\/mpd.2001.112648","article-title":"Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood","volume":"138","author":"Dluhy","year":"2001","journal-title":"Jornal de Pediatria"},{"key":"10.1016\/j.beem.2010.10.001_bib86","first-page":"319","article-title":"Aldosterone synthase inhibitors: pharmacological and clinical aspects","volume":"10","author":"Jansen","year":"2009","journal-title":"Current Opinion in Investigational Drugs"},{"key":"10.1016\/j.beem.2010.10.001_bib87","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clinical Science (London)"},{"key":"10.1016\/j.beem.2010.10.001_bib88","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","article-title":"Primary aldosteronism: cardiovascular, renal and metabolic implications","volume":"19","author":"Rossi","year":"2008","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib89","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1043-2760(01)00432-5","article-title":"Pathophysiological effects of aldosterone in cardiovascular tissues","volume":"12","author":"Rocha","year":"2001","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib90","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2010.10.001_bib91","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2010.10.001_bib92","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib93","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.beem.2010.10.001_bib94","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","article-title":"Remodeling of the left ventricle in primary aldosteronism due to conn\u2019s adenoma","volume":"95","author":"Rossi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2010.10.001_bib95","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"Journal of American Medical Association"},{"issue":"3","key":"10.1016\/j.beem.2010.10.001_bib96","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"Journal Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.beem.2010.10.001_bib97","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.110.157271","article-title":"Aldosterone Synthase Inhibition With LCI699. A Proof-of-Concept Study in Patients With Primary Aldosteronism","author":"Amar","year":"2010","journal-title":"Hypertension"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X10001284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X10001284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:42:24Z","timestamp":1761496944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X10001284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1521690X10001284"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2010.10.001","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of primary aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2010.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}